WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 15-Jul-2015 (Data received as of 10-Jul-2015)
Next overall update Fall 2015
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 5701 Infant (under 12 months) mortality rate: 812
GDP / capita (US$): 1'4291 Child (under 5 years) mortality rate: 1292

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 1'746  1'704  1'664  1'624  1'587  1'273  1'017  818 
Births 65  64  63  62  61  53  46  38 
Surviving infants 59  58  57  56  55  47  40  33 
Pop. less than 5 years 274  270  265  261  256  215  179  142 
Pop. less than 15 years 720  707  693  679  665  554  451  351 
Female 15-49 years 419  407  397  386  376  299  232  187 

Number of reported case

(Click for retrospective incidence data for Guinea-Bissau)
Diphtheria
Japanese encephalitis
Measles 26  259  1'332 
Mumps
Pertussis 1'512  1'250 
Polio*
Rubella 23 
Rubella (CRS)
Tetanus (neonatal) 45 
Tetanus (total)** 45  221 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Guinea-Bissau)
Vaccine year result method % card seen                                                
BCG 2009  94  MICS   83  94  95  95  99  93  90 
DTP1 2009  94  MICS   83  92  99*  90  99*  99* 
DTP3 2009  81  MICS   83  83  96  90  89  86  61 
DTP4         
IPV1         
HepB_BD         
HepB3          83  96  90  89  86 
Hib3          83  96  90  89  86 
JapEnc         
MCV1          81  89  90  78  78  53 
MCV2         
PCV1         
PCV3         
Pol3 2009  79  MICS   83  83  96  90  90  83  60 
Rota1         
Rota_last         
Rubella1         
TT2plus 2009  58  MICS   83  70  38  45  32  70  31 
PAB         
VAD1          94  79 
YFV 2009  57  MICS   83  75  73  90  78  78 
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Guinea-Bissau)
BCG 94  94  94  94  94  77  90 
DTP1 92  92  92  92  92  73  82 
DTP3 80  80  80  80  80  49  61 
HepB3 80  80  80  80  80 
HepB_BD
Hib3 80  80  80  80  80 
MCV1 69  69  69  69  69  71  53 
MCV2
PAB 80  80  80  80  78  49  40 
PCV3
Pol3 78  78  78  78  78  52  60 
Rota_last
YFV 53  69  69  69  69 

Number of districts in the country 11  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 36
From 80 to 89% 9
From 50 to 79% 55
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwP 6, 10, 14 weeks; Yes
DTwPHibHepB 6,10,14 weeks; Yes
IPV 14 weeks; Yes From October 2015
Measles 9 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes From April 2015
Rotavirus 6, 10 weeks; Yes From November 2015
TT 1st contact; +1, +6 months; +1, +1 year; Yes
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR   Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number   2013-2017  2013 - 2017  2010-2014  2010-2014  2010-2014   
Nº of districts with microplans that include activities to raise immunization coverage number   11  11    11  11 

System performance

Total Nº districts in country number 11  11  11  11  11  11  11 
Nº districts with DTP3 coverage >=80% number 10  10  10 
% of districts with DTP3 coverage >=80% From 0 to 100% 45  91  91  64  91  55 
Nº districts with measles (MCV1) coverage >=95% number
% of districts with MCV1 coverage >=95% From 0 to 100% 55  27  27  27 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  No  No  No  No     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  No  Yes  No  No  No 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100%            

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No  No     

Sources

 1  "The 2015 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.